The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Chen Jin-long since 2019.
This trader's CIK number is 1642996.
At the time of last reporting, Chen Jin-long was the Chief Scientific Officer of Ngm Biopharmaceuticals Inc. (stock ticker symbol NGM).
Also see all insider trading activities at Ngm Biopharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | NGM | 0 | $0 | 85,082 | $438,342 | 85,082 | $122,518 |
| 2021 | NGM | 0 | $0 | 275,000 | $6,689,505 | 219,444 | $189,999 |
| 2020 | NGM | 0 | $0 | 225,765 | $4,425,716 | 122,515 | $149,471 |
| 2019 | NGM | 0 | $0 | 50,765 | $654,797 | 122,515 | $138,169 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-01-17 | NGM | Option Ex | 85,082 | 1.44 | 122,518 |
| 2023-01-17 | NGM | Sale | 85,082 | 5.15 | 438,342 |
| 2021-12-06 | NGM | Option Ex | 69,444 | 1.44 | 99,999 |
| 2021-12-06 | NGM | Sale | 15,000 | 18.21 | 273,150 |
| 2021-12-07 | NGM | Sale | 15,000 | 18.60 | 279,000 |
| 2021-11-15 | NGM | Sale | 30,000 | 19.73 | 591,750 |
| 2021-10-11 | NGM | Sale | 15,000 | 20.41 | 306,150 |
| 2021-10-12 | NGM | Sale | 15,000 | 20.14 | 302,100 |
| 2021-09-14 | NGM | Sale | 15,000 | 25.84 | 387,525 |
| 2021-09-13 | NGM | Sale | 15,000 | 26.25 | 393,705 |
| 2021-08-09 | NGM | Sale | 15,000 | 24.85 | 372,750 |
| 2021-08-10 | NGM | Sale | 15,000 | 23.15 | 347,250 |
| 2021-05-03 | NGM | Sale | 25,000 | 27.62 | 690,500 |
| 2021-04-12 | NGM | Sale | 25,000 | 24.65 | 616,250 |
| 2021-03-01 | NGM | Sale | 25,000 | 26.66 | 666,500 |
| 2021-02-16 | NGM | Sale | 25,000 | 28.75 | 718,750 |
| 2021-01-05 | NGM | Option Ex | 150,000 | .60 | 90,000 |
| 2021-01-04 | NGM | Sale | 25,000 | 29.77 | 744,125 |
| 2020-12-14 | NGM | Sale | 25,000 | 28.22 | 705,575 |
| 2020-11-02 | NGM | Sale | 25,000 | 17.70 | 442,500 |
| 2020-10-12 | NGM | Sale | 25,000 | 17.02 | 425,500 |
| 2020-09-01 | NGM | Sale | 25,000 | 17.97 | 449,250 |
| 2020-08-10 | NGM | Sale | 25,000 | 19.02 | 475,500 |
| 2020-07-01 | NGM | Sale | 25,000 | 19.00 | 474,875 |
| 2020-06-15 | NGM | Sale | 25,000 | 21.47 | 536,750 |
| 2020-01-09 | NGM | Sale | 18,641 | 17.95 | 334,605 |
| 2020-01-08 | NGM | Sale | 16,034 | 17.98 | 288,291 |
| 2020-01-09 | NGM | Option Ex | 18,641 | 1.44 | 26,843 |
| 2020-01-07 | NGM | Sale | 16,090 | 18.20 | 292,870 |
| 2020-01-08 | NGM | Option Ex | 87,784 | 1.13 | 99,459 |
| 2020-01-07 | NGM | Option Ex | 16,090 | 1.44 | 23,169 |
| 2019-10-31 | NGM | Option Ex | 28,376 | 1.44 | 40,861 |
| 2019-11-01 | NGM | Sale | 11,403 | 13.29 | 151,523 |
| 2019-11-04 | NGM | Option Ex | 10,986 | 1.44 | 15,819 |
| 2019-10-31 | NGM | Sale | 28,376 | 12.99 | 368,575 |
| 2019-11-04 | NGM | Sale | 10,986 | 12.26 | 134,699 |
| 2019-11-01 | NGM | Option Ex | 83,153 | .98 | 81,489 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chen Jin-long (Chief Scientific Officer of Ngm Biopharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.